Table 3 |
|||
|
Regression analysis between individual components of the SEVR and inflammation in the primary cohort |
|||
|
Log ESR |
Log CRP |
DAS28 |
|
|
|
|||
|
Primary cohort |
|||
|
DTI |
β = -0.26, P = 0.001 |
β = -0.17, P = 0.03 |
β = -0.20, P = 0.004 |
|
TTI |
β = 0.02, P = 0.85 |
β = 0.13, P = 0.08 |
β = -0.006, P = 0.38 |
|
HR |
β = 0.18, P = 0.02 |
β = 0.32, P < 0.001 |
β = 0.13, P = 0.006 |
|
Validation cohort |
|||
|
DTI |
β = -0.02, P = 0.81 |
β = -0.053, P = 0.56 |
n/a |
|
TTI |
β = 0.16, P = 0.10 |
β = 0.28, P = 0.002 |
n/a |
|
HR |
β = 0.85, P = 0.37 |
β = -0.27, P = 0.01 |
n/a |
|
|
|||
|
CRP, C-reactive protein; DAS28, Disease Activity Score in 28 joints; DTI, diastolic time index; ESR, erythrocyte sedimentation rate; HR, heart rate; n/a, not available; SEVR, subendocardial viability ratio; TTI, tension time index. Bold data represent statistically significant results. |
|||
|
Sandoo et al. Arthritis Research & Therapy 2012 14:R258 doi:10.1186/ar4103 |
|||